尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Bohen Sean, 首席执行官. Insider active across 1 company, notably Olema Pharmaceuticals, Inc.. In total, 9 reports have been logged. Split: 1 buy · 0 sell. History available since 1 September 2021. The latest transaction was filed on 26 December 2025 (Don). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Bohen Sean is Directeur Général and serves as President and CEO at Olema Pharmaceuticals, Inc. The record shows 9 filings in total, and across the 9 sampled filings between 2021-09-03 and 2025-12-30, the most frequent transaction nature is option exercise, with sum_buy_eur at 0 and sum_sell_eur at 0.